O-001Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors. (20th June 2018) - Meric-Bernstam, F; Arkenau, H; Tran, B; Bahleda, R; Kelley, R; Hierro, C; Ahn, D; Zhu, A; Javle, M; Winkler, R; He, H; Huang, J; et al.